Consumer Feels Like...
Health Care: Drugs
Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)
$1.61 0.00 | 0.00%
02/09/12 - 04:00 PM ET
141.52K / 119.80K
Vol / Avg. Vol:1.61 / 1.61
Open / Prev. Close:1.61 - 1.65
Today's Range:1.01 - 3.16
52 Wk Range:37.61%
Performance YTD:TheStreet Rating:
Portfolios with SNSS
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- UserASCO 2010
- User1nhiaic2
- UserM0nkD Portfolio 1
- UsernewInvestor
- Usermsrapp
- Userjsandresen1 Portfolio 1
- Userpw's biotechs
- Usersgtbil Portfolio 1
- Userdon698 Portfolio 1
Latest SNSS Headlines from TheStreet
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- ASCO: Traders Love Speculative Cancer Stocks 05.19.11 | 06:05 am
- Sunesis To Present At The 10th Annual Needham Healthcare Conference 03.30.11 | 07:03 am
- Sunesis Pharmaceuticals Reports Fourth Quarter And Full-Year 2010 Financial Results 03.29.11 | 07:03 am
- Stock Offerings: Isle of Capri Casinos 07.01.10 | 11:07 am
- Arena Pharma, Sunesis: Volume Movers 07.01.10 | 07:07 am
- Biotech Stock Mailbag: ASCO 06.11.10 | 07:06 am
- ASCO Live Blog: Monday 06.07.10 | 07:06 am
- 13 ASCO Stocks Presenting New Clinical Data 05.21.10 | 06:05 am
- ASCO's Abstract Release Day: Preview 05.19.10 | 06:05 am
Press Releases for SNSS
Partner Headlines for SNSS
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- 6 Speculative Biotech Stocks Smart Money Loves - Seeking Alpha 05.23.11 | 09:05 am
- Cyclin-Dependent Cancer Confab Preview - SeekingAlpha.com 04.17.10 | 04:04 pm
- UPDATE 1-Sunesis to advance cancer drug development, shares rise - Reuters 02.25.10 | 08:02 am
